Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients.

Autor: Iwamoto FM; Columbia University, New York, NY, United States., Tanguturi SK; Brigham and Women's Hospital, Boston, Massachusetts, United States., Nayak L; Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, United States., Wang TJ; Columbia University Medical Center, New York, New York, United States., Desai A; University of Pennsylvania, Philadelphia, PA, United States., Lustig RA; University of Pennsylvania, Philadelphia, PA, United States., Bagley S; University of Pennsylvania, Philadelphia, Pa, United States., Wong ET; Beth Israel Deaconess Med Ctr, Boston, MA, United States., Hertan LM; Beth Israel Deaconess Medical Center, Boston, MA, United States., McCluskey C; Dana-Farber Cancer Institute, Boston, MA, United States., Hayden J; Massachusetts General Hospital, Boston, MA, United States., Muzikansky A; Massachusetts General Hospital, Boston, MA, United States., Nakhawa S; Dana-Farber Cancer Institute, Boston, MA, United States., Japo J; Dana-Farber Cancer Institute, United States., Bossi CC; Dana-Farber Cancer Institute., Meylan M; Centre de Recherche des Cordeliers, Inserm UMRS 1138, Paris, France., Tian Y; Dana-Farber Cancer Institute, United States., Barlow GL; Dana-Farber Cancer Institute, United States., Speliakos P; Dana-Farber Cancer Institute, United States., Ayoub G; Dana-Farber Cancer Institute, Boston, United States., Meredith DM; Dana-Farber Cancer Institute, United States., Ligon KL; Dana-Farber Cancer Institute, Boston, MA, United States., Haas-Kogan D; Dana-Farber Cancer Institute, Boston, MA, United States., Huang K; Dana-Farber/Brigham and Women's Cancer Center, United States., Wucherpfennig KW; Dana-Farber Cancer Institute, Boston, MA, United States., Wen PY; Dana-Farber Cancer Institute, Boston, MA, United States., Reardon DA; Dana-Farber Cancer Institute, Boston, MA, United States.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 08. Date of Electronic Publication: 2024 Nov 08.